Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

Wells Fargo analyst Mohit Bansal maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target ...

BofA raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $567 from $555 and keeps a Buy rating on the shares. After having ...

Currently, neither existing classical nor quantum algorithms can solve these problems in polynomial time. To address this difficulty, this paper proposes a quantum feasibility labeling (QFL) algorithm ...

As of 1:23:47 PM EDT. Market Open.